The response of myeloproliferative neoplasms with PCM1-JAK2 fusion genes can be long-lived, without use of allogeneic bone marrow transplantation
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene
RUMI, ELISA;CAZZOLA, MARIO;
2015-01-01
Abstract
The response of myeloproliferative neoplasms with PCM1-JAK2 fusion genes can be long-lived, without use of allogeneic bone marrow transplantationFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
